Thursday, January 8, 2026

1/8/2026

Today's market scan highlights diverse opportunities across Communication Services, Health Care, and Information Technology. We focus on four standout tickers showing interesting technical setups and fundamental strength: ABBV, CIEN, GOOG, and LLY. From pharmaceutical giants driving innovation to tech leaders expanding infrastructure, these selections embody our philosophy: "Quality Stocks, Beautiful Trends."

Communication Services

GOOG - Alphabet Inc.

Interactive Media & Services

Alphabet continues to dominate the digital landscape, leveraging its unparalleled market share in Search and YouTube to drive robust advertising revenue. The company is aggressively integrating Gemini AI across its ecosystem, aiming to redefine user interaction and search capabilities. Google Cloud remains a significant growth engine, steadily capturing market share in enterprise cloud computing. With a fortress balance sheet and massive free cash flow, Alphabet is well-positioned to fund its AI capital expenditures. Investors are monitoring the company's ability to monetize these AI innovations while navigating regulatory scrutiny.

Weekly Trend (Long Term) GOOG Weekly Chart
Daily Action (Short Term) GOOG Daily Chart

Health Care

ABBV - AbbVie Inc.

Biotechnology

AbbVie has successfully navigated the patent cliff for its blockbuster drug Humira by rapidly expanding its immunology portfolio with Skyrizi and Rinvoq. The company boasts a diversified pipeline with strong momentum in oncology and neuroscience, bolstered by recent strategic acquisitions. Known for its reliable dividend growth, AbbVie remains a favorite among income-oriented investors seeking stability. Management has raised guidance, reflecting confidence in the commercial execution of its newer assets. The stock continues to show resilience as it transitions into its next phase of growth.

Weekly Trend (Long Term) ABBV Weekly Chart
Daily Action (Short Term) ABBV Daily Chart

LLY - Eli Lilly and Company

Pharmaceuticals

Eli Lilly stands at the forefront of the pharmaceutical industry, driven by unprecedented demand for its GLP-1 treatments, Mounjaro and Zepbound. The company is investing heavily to expand manufacturing capacity to address supply shortages in the diabetes and obesity markets. Beyond metabolic diseases, Lilly has a promising pipeline in Alzheimer's disease research, which could serve as another major catalyst. While valuation multiples are premium, they reflect the company's exceptional growth trajectory and market leadership. Analysts remain bullish on the long-term adoption rates of its key therapies.

Weekly Trend (Long Term) LLY Weekly Chart
Daily Action (Short Term) LLY Daily Chart

Information Technology

CIEN - Ciena Corporation

Communications Equipment

Ciena is a key enabler of modern digital infrastructure, providing the optical networking solutions necessary for high-speed data transmission. As the proliferation of AI applications drives massive increases in bandwidth demand, cloud providers and telcos are upgrading their networks with Ciena's coherent optical technology. The company is benefiting from normalizing inventory levels across the industry and a strong backlog of orders. Ciena's leadership in 800G and 1.6T networking places it in a prime position to capitalize on the next wave of data center expansion. Technicals suggest growing interest as infrastructure spending ramps up.

Weekly Trend (Long Term) CIEN Weekly Chart
Daily Action (Short Term) CIEN Daily Chart